Kingworld Medicines Group P/E 2024

Kingworld Medicines Group P/E

11.35

Kingworld Medicines Group Dividend yield

4.23 %

Ticker

1110.HK

ISIN

KYG5268M1006

As of May 25, 2024, Kingworld Medicines Group's P/E ratio was 11.35, a 2.34% change from the 11.09 P/E ratio recorded in the previous year.

The Kingworld Medicines Group P/E history

Kingworld Medicines Group Aktienanalyse

What does Kingworld Medicines Group do?

Kingworld Medicines Group ist eines der beliebtesten Unternehmen auf Eulerpool.com.

P/E Details

Deciphering Kingworld Medicines Group's P/E Ratio

The Price to Earnings (P/E) Ratio of Kingworld Medicines Group is a vital metric that investors and analysts use to determine the company’s market value relative to its earnings. It is calculated by dividing the current stock price by the earnings per share (EPS). A higher P/E ratio could suggest that investors are expecting higher future growth, while a lower ratio may indicate a potentially undervalued company or lower growth expectations.

Year-to-Year Comparison

Assessing Kingworld Medicines Group's P/E ratio on a yearly basis provides insights into the valuation trends and investor sentiment. An increasing P/E ratio over the years signifies growing investor confidence and expectations for future earnings growth, while a decreasing ratio may reflect concerns over the company's profitability or growth prospects.

Impact on Investments

The P/E ratio of Kingworld Medicines Group is a key consideration for investors aiming to balance risk and reward. A comprehensive analysis of this ratio, in conjunction with other financial indicators, aids investors in making informed decisions regarding buying, holding, or selling the company’s stocks.

Interpreting P/E Ratio Fluctuations

Fluctuations in Kingworld Medicines Group’s P/E ratio can be attributed to various factors including changes in earnings, stock price movements, and shifts in investor expectations. Understanding the underlying reasons for these fluctuations is essential for predicting future stock performance and assessing the company's intrinsic value.

Frequently Asked Questions about Kingworld Medicines Group Stock

What is the price-to-earnings ratio of Kingworld Medicines Group?

The price-earnings ratio of Kingworld Medicines Group is currently 11.35.

How has the price-earnings ratio of Kingworld Medicines Group changed compared to last year?

The price-to-earnings ratio of Kingworld Medicines Group has increased by 2.34% increased compared to last year.

What consequences does a high price-earnings ratio have for investors?

A high price-to-earnings ratio indicates that the company's stock is relatively expensive and investors may potentially achieve a lower return.

What does a low price-earnings ratio mean?

A low price-earnings ratio means that the company's stock is relatively cheap and investors may potentially achieve a higher return.

Is the price-earnings ratio of Kingworld Medicines Group high compared to other companies?

Yes, the price-to-earnings ratio of Kingworld Medicines Group is high compared to other companies.

How does an increase in the price-earnings ratio of Kingworld Medicines Group affect the company?

An increase in the price-earnings ratio of Kingworld Medicines Group would lead to a higher market capitalization of the company, which in turn would lead to a higher valuation of the company.

How does a reduction in the price-to-earnings ratio of Kingworld Medicines Group affect the company?

A decrease in the price-earnings ratio of Kingworld Medicines Group would result in a lower market capitalization of the company, which in turn would lead to a lower valuation of the company.

What are some factors that influence the price-earnings ratio of Kingworld Medicines Group?

Some factors that influence the price-earnings ratio of Kingworld Medicines Group are the company's growth, financial position, industry development, and the overall economic situation.

How much dividend does Kingworld Medicines Group pay?

Over the past 12 months, Kingworld Medicines Group paid a dividend of 0.02 CNY . This corresponds to a dividend yield of about 4.23 %. For the coming 12 months, Kingworld Medicines Group is expected to pay a dividend of 0.02 CNY.

What is the dividend yield of Kingworld Medicines Group?

The current dividend yield of Kingworld Medicines Group is 4.23 %.

When does Kingworld Medicines Group pay dividends?

Kingworld Medicines Group pays a quarterly dividend. This is distributed in the months of July, June, July, July.

How secure is the dividend of Kingworld Medicines Group?

Kingworld Medicines Group paid dividends every year for the past 13 years.

What is the dividend of Kingworld Medicines Group?

For the upcoming 12 months, dividends amounting to 0.02 CNY are expected. This corresponds to a dividend yield of 4.23 %.

In which sector is Kingworld Medicines Group located?

Kingworld Medicines Group is assigned to the 'Health' sector.

Wann musste ich die Aktien von Kingworld Medicines Group kaufen, um die vorherige Dividende zu erhalten?

To receive the latest dividend of Kingworld Medicines Group from 6/30/2024 amounting to 0.034 CNY, you needed to have the stock in your portfolio before the ex-date on 6/3/2024.

When did Kingworld Medicines Group pay the last dividend?

The last dividend was paid out on 6/30/2024.

What was the dividend of Kingworld Medicines Group in the year 2023?

In the year 2023, Kingworld Medicines Group distributed 0.024 CNY as dividends.

In which currency does Kingworld Medicines Group pay out the dividend?

The dividends of Kingworld Medicines Group are distributed in CNY.

Stock savings plans offer an attractive way for investors to build wealth over the long term. One of the main advantages is the so-called cost-average effect: by regularly investing a fixed amount in stocks or stock funds, you automatically buy more shares when prices are low, and fewer when they are high. This can lead to a more favorable average price per share over time. In addition, stock savings plans allow small investors access to expensive stocks, as they can participate with small amounts. Regular investment also promotes a disciplined investment strategy and helps to avoid emotional decisions, such as impulsive buying or selling. Furthermore, investors benefit from the potential appreciation of the stocks as well as from dividend distributions, which can be reinvested, enhancing the compounding effect and thus the growth of the invested capital.

Andere Kennzahlen von Kingworld Medicines Group

Our stock analysis for Kingworld Medicines Group Revenue stock includes important financial indicators such as revenue, profit, P/E ratio, P/S ratio, EBIT, as well as information on dividends. We also assess aspects such as stocks, market capitalization, debt, equity, and liabilities of Kingworld Medicines Group Revenue. If you are looking for more detailed information on these topics, we offer comprehensive analyses on our subpages.